Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.27B |
| 2 |
Blackrock
BLK
|
+$1.21B |
| 3 |
PG&E
PCG
|
+$1.17B |
| 4 |
Alibaba
BABA
|
+$1.12B |
| 5 |
T-Mobile US
TMUS
|
+$826M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$1.34B |
| 2 |
Boston Scientific
BSX
|
+$1.26B |
| 3 |
American Express
AXP
|
+$1.23B |
| 4 |
GE Aerospace
GE
|
+$1.1B |
| 5 |
Visa
V
|
+$993M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.88% |
| 2 | Healthcare | 16.37% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.24% |
| 5 | Communication Services | 10.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Hyster-Yale Materials Handling
HY
$665M
| $11.3M | ﹤0.01% |
291,444
-100
| -0% | -$3.73K |
|
|
NXRT
1727
NexPoint Residential Trust
NXRT
$652M
| $11.3M | ﹤0.01% |
318,562
+318,396
| +191,805% | +$9.85M |
|
1728
Quanterix
QTRX
$190M
| $11.2M | ﹤0.01% |
408,100
-107,987
| -21% | -$2.73M |
|
1729
Franklin Covey
FC
$246M
| $11.1M | ﹤0.01% |
519,110
+63
| +0% | +$1.28K |
|
|
PRVL
1730
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $11.1M | ﹤0.01% |
742,000
-46,600
| -6% | -$718K |
|
|
QVCGA
1731
DELISTED
QVC Group Inc Series A
QVCGA
| $11M | ﹤0.01% |
23,897
+13,340
| +126% | +$5.21M |
|
1732
American Eagle Outfitters
AEO
$3.01B
| $11M | ﹤0.01% |
1,010,205
+995,454
| +6,748% | +$9.41M |
|
1733
Winnebago Industries
WGO
$909M
| $11M | ﹤0.01% |
164,480
+81,996
| +99% | +$4.19M |
|
1734
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
| $10.9M | ﹤0.01% |
102,322
-108,185
| -51% | -$10.9M |
|
1735
ORIX
IX
$43.5B
| $10.8M | ﹤0.01% |
880,350
+166,005
| +23% | +$2.04M |
|
|
AEPPL
1736
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $10.8M | ﹤0.01% |
222,400
+20,000
| +10% | +$1M |
|
1737
Vicor
VICR
$10.2B
| $10.8M | ﹤0.01% |
150,182
+149,932
| +59,973% | +$8.42M |
|
1738
Tyler Technologies
TYL
$12.8B
| $10.7M | ﹤0.01% |
30,932
+15,344
| +98% | +$5.15M |
|
|
AMTD
1739
DELISTED
TD Ameritrade Holding Corp
AMTD
| $10.7M | ﹤0.01% |
293,773
-30,746
| -9% | -$1.16M |
|
|
GMLP
1740
DELISTED
Golar LNG Partners LP
GMLP
| $10.6M | ﹤0.01% |
4,126,578
-1
| -0% | -$3 |
|
1741
Ralph Lauren
RL
$23.6B
| $10.6M | ﹤0.01% |
145,798
-253,404
| -63% | -$18.6M |
|
1742
Civeo
CVEO
$318M
| $10.5M | ﹤0.01% |
1,425,835
| – | – |
|
1743
Invesco S&P 500 Pure Value ETF
RPV
$1.71B
| $10.5M | ﹤0.01% |
220,975
-706,969
| -76% | -$32.2M |
|
1744
H.B. Fuller
FUL
$3.28B
| $10.5M | ﹤0.01% |
235,609
+234,881
| +32,264% | +$8.53M |
|
1745
Kulicke & Soffa
KLIC
$4.78B
| $10.5M | ﹤0.01% |
503,215
+502,392
| +61,044% | +$11.4M |
|
1746
Avient
AVNT
$4.19B
| $10.4M | ﹤0.01% |
397,110
+396,639
| +84,212% | +$9.21M |
|
1747
First Northwest Bancorp
FNWB
$104M
| $10.3M | ﹤0.01% |
829,334
-75,091
| -8% | -$882K |
|
1748
Precision BioSciences
DTIL
$207M
| $10.2M | ﹤0.01% |
40,686
-40,687
| -50% | -$8.91M |
|
1749
Geospace Technologies
GEOS
$75.7M
| $10.2M | ﹤0.01% |
1,350,636
+289
| +0% | +$1.92K |
|
1750
MPLX
MPLX
$59.7B
| $10.1M | ﹤0.01% |
586,171
-6,900
| -1% | -$118K |
|
Similar funds
Fidelity Investments's Q2 2020 Portfolio in Review
As of Q2 2020, Fidelity Investments held 4,490 positions worth $909B, up 26% from $722B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Fidelity Investments's Q2 2020 filing shows 334 new, 1,365 increased, 1,743 reduced and 502 closed positions. Its largest new stake was Royalty Pharma: 16,356,491 shares worth $743M. The largest sale was iShares US Treasury Bond ETF, an estimated $1.34B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fidelity Investments's largest Q2 2020 buy was Royalty Pharma: 16,356,491 shares worth $743M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q2 2020, an estimated $2.27B increase.
- Fidelity Investments's biggest Q2 2020 reduction was iShares US Treasury Bond ETF, cutting an estimated $1.34B.
- Fidelity Investments fully exited Sprint Corporation in Q2 2020, selling an estimated $225M.
- Fidelity Investments's ten largest holdings make up 28% of its $909B portfolio in Q2 2020.
- Fidelity Investments opened 334 new positions and closed 502 in Q2 2020.
- Fidelity Investments's portfolio value rose 26% quarter-over-quarter to $909B.
Based on Fidelity Investments's 13F filing for Q2 2020, filed 13 Aug 2020.